DENKHAUS DONALD A 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Feb 6, 2024
Insider Transaction Report
Form 4
DENKHAUS DONALD A
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2024-02-05$4.01/sh+40,000$160,400→ 434,333 total - Exercise/Conversion
Options to purchase common stock
2024-02-05−40,000→ 192,931 totalExercise: $4.01Exp: 2025-01-02→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Derivative securities vested in three equal tranches on January 2, 2019, 2020 and 2021.